Semaglutide Weight Management and Cardiovascular Risk Reduction slide image

Semaglutide Weight Management and Cardiovascular Risk Reduction

Obesity is associated with multiple comorbidities, which may be improved with weight management Life expectancy decreases as BMI increases¹ Obesity related comorbidities² Normal BMI Almost 80% chance of reaching age 70 Mental ⚫ Depression Anxiety BMI 35-40 kg/m² ~60% chance of reaching age 70 BMI 40-50 kg/m² -50% chance of reaching age 70 Mechanical Asthma GERD Physical functioning • Incontinence Knee osteoarthritis Sleep apnea Chronic back pain Metabolic NAFLD Gallstones Infertility Type 2 diabetes Prediabetes Thrombosis Gout Cancers* CVD: • Stroke Dyslipidemia • Hypertension Coronary artery disease HFPEF *Including breast, colorectal, endometrial, oesophageal, kidney, ovarian, pancreatic and prostate 1 Prospective Studies Collaboration. Lancet. 2009;373:1083-96. 2 Adapted from Sharma AM. Obes Rev 2010;11:808-9; Guh DP et al. BMC Public Health 2009;9:88; Luppino FS et al. Arch Gen Psychiatry 2010;67:220-9; Simon GE et al. Arch Gen Psychiatry 2006;63:824-30; Church TS et al. Gastroenterology 2006;130:2023-30; Li C et al. Prev Med 2010;51:18-23; Hosler AS. Prev Chronic Dis 2009;6:A48. BMI: Body mass index; GERD: gastro-oesophageal reflux disease; HFPEF: heart failure with preserved ejection fraction; NAFLD: non-alcoholic fatty liver disease; CVD: Cardiovascular disease; HFPEF: Heart failure with preserved ejection fraction
View entire presentation